The Cancer Letter

Inside information on cancer research and drug development

Vol.
45
No.
12
March 22, 2019Mar 22, 2019
DOWNLOAD THE PDF
Texas cancer researchers vying to renew CPRIT beyond its 2023 sunset date The institute is spending more than NCI in the state
Cover Story

Texas cancer researchers vying to renew CPRIT beyond its 2023 sunset date

The institute is spending more than NCI in the state
By Claire Dietz and Matthew Bin Han Ong
The Cancer Prevention and Research Institute of Texas—the second largest publicly-funded granting organization for cancer after NIH—may receive $3 billion more to stay open past its current sunset date in 2023.
James Willson: CPRIT is money well spent
Conversation with The Cancer Letter
By Claire Dietz and Matthew Bin Han Ong
SWOG's 1501 study takes aim at the silo wall between cardiology and oncology
ClinicalFreeTrials & Tribulations
By Justin Floyd

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account